| Followers | 843 |
| Posts | 123033 |
| Boards Moderated | 9 |
| Alias Born | 09/05/2002 |
Thursday, March 24, 2022 9:25:07 AM
NEOG FY3Q22 financials:
https://www.prnewswire.com/news-releases/neogen-announces-third-quarter-results-301509892.html No CC.
https://www.prnewswire.com/news-releases/neogen-announces-third-quarter-results-301509892.html
Net income for the third quarter was $5,443,000, or $0.05 per share, adversely impacted by $10.6 million of professional fees incurred in connection with Neogen's plan to combine 3M's Food Safety business with the company's existing operations, which was announced on December 14, 2021. Excluding the 3M deal-related costs, net income for the quarter would have been $13,600,000, or $0.13 per share, compared to $13,377,000, or $0.12 per share, in the previous year's third quarter.
“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”
Recent NEOG News
- Form SD - Specialized disclosure report • Edgar (US Regulatory) • 05/20/2026 02:53:38 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/19/2026 12:37:43 PM
- Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend] • Edgar (US Regulatory) • 05/14/2026 05:39:20 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/04/2026 08:52:49 PM
- Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors • Edgar (US Regulatory) • 04/30/2026 03:36:13 PM
- Neogen’s Listeria Right Now™ Test Receives AOAC® Performance Tested Methods℠ Certification • Business Wire • 04/23/2026 12:45:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 04/20/2026 10:59:24 AM
- Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 04/13/2026 12:29:20 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 04/09/2026 08:03:42 PM
- Neogen tops estimates as food safety segment drives growth • IH Market News • 04/09/2026 02:56:39 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 04/09/2026 11:01:47 AM
- Neogen Reports Third Quarter Fiscal Year 2026 Financial Results • Business Wire • 04/09/2026 11:00:00 AM
- Neogen® Corporation Announces Appointment of Jennifer Evans Stacey as Chief Legal & Compliance Officer and Board Secretary • Business Wire • 04/08/2026 12:00:00 PM
- Neogen to Release Third-Quarter Fiscal Year 2026 Financial Results on April 9, 2026 • Business Wire • 03/30/2026 06:50:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/30/2026 12:19:36 PM
- Neogen to Release Third-Quarter Fiscal Year 2026 Financial Results on April 9, 2026 • Business Wire • 03/30/2026 12:00:00 PM
- Zoetis shares slip after announcing $160M acquisition of Neogen genomics unit • IH Market News • 03/02/2026 04:14:34 PM
- Neogen Announces Sale of Genomics Business to Zoetis • Business Wire • 03/02/2026 12:00:00 PM
- Zoetis to Acquire Animal Genomics Business from Neogen®, Accelerating Precision Animal Health Innovation • Business Wire • 03/02/2026 12:00:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/17/2026 08:12:55 PM
- Neogen Issues Voluntary Nationwide Recall of Neogen®Vet HYCOAT® Hyaluronate Sodium Sterile Solution • Business Wire • 01/28/2026 11:27:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/26/2026 02:34:27 PM
